十年数字乳腺断层摄影筛查中检出的乳腺癌:与数字乳腺X线摄影的比较
该回顾性研究分析了2008年8月至2021年7月筛查检出的1407例乳腺癌(数字乳腺X线摄影142例,数字乳腺断层摄影1265例),比较两种方法检出的癌症类型与分期。数字乳腺断层摄影的癌症检出率更高(每1000例5.3 vs 4例,P=0.001),浸润性癌中晚期癌症比例更低(32.6% vs 43.6%,P=0.04),且数字乳腺断层摄影的 incident 筛查较 prevalent 筛查晚期癌症比例进一步降低(29.1% vs 39.1%,P=0.003);两组间期癌发生率无差异(每1000例0.14 vs 0.2,P=0.42)。
要点
- 数字乳腺断层摄影筛查的癌症检出率高于数字乳腺X线摄影(每1000例5.3 vs 4例,P=0.001)。
- 数字乳腺断层摄影检出的浸润性癌中晚期癌症比例低于数字乳腺X线摄影(32.6% vs 43.6%,P=0.04)。
- 数字乳腺断层摄影 incident 筛查较 prevalent 筛查晚期癌症比例更低(29.1% vs 39.1%,P=0.003)。
核心结论
- 数字乳腺断层摄影有助于提高乳腺癌检出率,且与数字乳腺X线摄影相比,检出的浸润性癌中晚期癌症比例更低,在 incident 筛查轮次中观察到进一步改善。
研究设计与样本
- 回顾性研究,通过回顾性检索识别2008年8月至2021年7月经筛查乳腺X线摄影检出的乳腺癌,共分析1407例(数字乳腺X线摄影142例,数字乳腺断层摄影1265例),收集人口学、影像和病理信息,比较两种筛查方式并按 prevalent 与 incident 检查进一步分析,同时评估假阴性结果。
关键影像表现/征象
- 数字乳腺断层摄影的癌症显示率高于数字乳腺X线摄影(每1000例5.3 vs 4例,P=0.001)。
- 数字乳腺X线摄影与数字乳腺断层摄影的浸润性癌与导管原位癌比例相似(71.1%:28.9% [101和41/142] vs 76.5%:23.5% [968和297/1265])。
- 数字乳腺X线摄影与数字乳腺断层摄影的浸润性癌平均大小无差异(1.44 cm ± 0.93 vs 1.36 cm ± 1.14,P=0.49),但数字乳腺断层摄影 incident 病例小于 prevalent 病例(1.2 cm ± 1.0 vs 1.6 cm ± 1.4,P<0.001)。
- 数字乳腺X线摄影与数字乳腺断层摄影的浸润性癌亚型分级比例相似:低级别(29% [28/96] vs 26.5% [243/912])、中级别(51% [49/96] vs 57.2% [522/912])、高级别(20% [19/96] vs 16.1% [147/912])(P=0.65)。
诊断标准与关键数值
- 晚期癌症定义为:浸润性癌大小≥2 cm、人表皮生长因子受体2阳性或三阴性肿瘤大于10 mm、腋窝淋巴结癌阳性、或远处器官转移。
- 数字乳腺断层摄影较数字乳腺X线摄影的晚期癌症比例更低(32.6% [316/968] vs 43.6% [44/101],P=0.04)。
- 数字乳腺断层摄影 prevalent 筛查较 incident 筛查的晚期癌症比例更高(39.1% [133/340] vs 29.1% [183/628],P=0.003)。
- 数字乳腺X线摄影与数字乳腺断层摄影的间期癌发生率无差异(每1000例0.14 vs 0.2,P=0.42)。
临床应用与阅片要点
- 数字乳腺断层摄影筛查可提高乳腺癌检出率,并检出晚期癌症比例更低的浸润性癌(32.6% vs 43.6%,P=0.04)。
- 数字乳腺断层摄影 incident 筛查较 prevalent 筛查检出更小的浸润性癌(1.2 cm ± 1.0 vs 1.6 cm ± 1.4,P<0.001)和更低的晚期癌症比例(29.1% vs 39.1%,P=0.003)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Digital breast tomosynthesis (DBT) has been shown to help increase cancer detection compared with two-dimensional digital mammography (DM). However, it is unclear whether additional tumor detection will improve outcomes or lead to overdiagnosis of breast cancer. Purpose This study aimed to compare cancer types and stages over 3 years of DM screening and 10 years of DBT screening to determine the effect of DBT. Materials and Methods A retrospective search identified breast cancers detected by using screening mammography from August 2008 through July 2021. Data collected included demographic, imaging, and pathologic information. Invasive cancers 2 cm or larger, human epidermal growth factor 2-positive or triple-negative tumors greater than 10 mm, axillary nodes positive for cancer, and distant organ spread were considered advanced cancers. The DBT and DM cohorts were compared and further analyzed by prevalent versus incident examinations. False-negative findings were also assessed. Results A total of 1407 breast cancers were analyzed (142 with DM, 1265 with DBT). DBT showed a higher rate of cancer depiction than DM (5.3 vs four cancers per 1000, respectively; P = .001), with a similar ratio of invasive cancers to ductal carcinomas in situ (76.5%:23.5% [968 and 297 of 1265, respectively] vs 71.1%:28.9% [101 and 41 of 142, respectively]). Mean invasive cancer size did not differ between DM and DBT (1.44 cm ± 0.93 [SD] vs 1.36 cm ± 1.14, respectively; P = .49), but incident DBT cases were smaller than prevalent cases (1.2 cm ± 1.0 vs 1.6 cm ± 1.4, respectively; P < .001). DBT and DM had similar rates of invasive cancer subtypes: low grade (26.5% [243 of 912] vs 29% [28 of 96], respectively), moderate grade (57.2% [522 of 912] vs 51% [49 of 96], respectively), and high grade (16.1% [147 of 912] vs 20% [19 of 96], respectively) (P = .65). The proportion of advanced cancers was lower with DBT than DM (32.6% [316 of 968] vs 43.6% [44 of 101], respectively; P = .04) and between DBT prevalent and incident screening (39.1% [133 of 340] vs 29.1% [183 of 628], respectively; P = .003). There was no difference in interval cancer rates (0.14 per 1000 with DM and 0.2 per 1000 with DBT; P = .42) for both groups. Conclusion DBT helped to increase breast cancer detection rate and depicted invasive cancers with a lower rate of advanced cancers compared with DM, with further improvement observed at incident rounds of screening. © RSNA, 2024 See also the editorial by Kim and Woo in this issue.
引用
- Philpotts LE, Grewal JK, Horvath LJ, et al. Breast Cancers Detected during a Decade of Screening with Digital Breast Tomosynthesis: Comparison with Digital Mammography. Radiology. 2024. PMID: 39287520. doi:10.1148/radiol.232841
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。